Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    IO Biotech Inc.

    NASDAQ: IOBT · Real-Time Price · USD
    1.39
    -0.05 (-3.47%)
    At close: Jun 30, 2025, 3:59 PM

    IO Biotech Statistics

    Share Statistics

    IO Biotech has 65.88M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 65.88M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 29.89%

    Shares Floating

    n/a
    		 48.43M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,000

    FTD / Avg. Volume

    n/a
    		 0.65%

    Short Selling Information

    The latest short interest is 139.28K, so 0.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 139.28K

    Short % of Shares Out

    n/a
    		 0.21%

    Short % of Float

    n/a
    		 0.44%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.63 and the forward PE ratio is -1.29. IO Biotech's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.63

    Forward PE

    n/a
    		 -1.29

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 1.29

    P/FCF Ratio

    n/a
    		 -0.74

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for IO Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 3.33

    Quick Ratio

    n/a
    		 3.33

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,193,637.5

    Employee Count

    n/a
    		 80

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.44M

    Effective Tax Rate

    n/a
    		 -1.53%

    Stock Price Statistics

    The stock price has increased by 24.11% in the last 52 weeks. The beta is 0.37, so IO Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.37

    52-Week Price Change

    n/a
    		 24.11%

    50-Day Moving Average

    n/a
    		 1.2

    200-Day Moving Average

    n/a
    		 1.03

    Relative Strength Index (RSI)

    n/a
    		 53.26

    Average Volume (20 Days)

    n/a
    		 154,724

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -95.18M

    Net Income

    n/a
    		 -95.49M

    EBITDA

    n/a
    		 -93.2M

    EBIT

    n/a
    		 -94.05M

    Earnings Per Share (EPS)

    n/a
    		 -1.45
    Full Income Statement

    Balance Sheet

    The company has 60.03M in cash and 1.92M in debt, giving a net cash position of 58.12M.

    Cash & Cash Equivalents

    n/a
    		 60.03M

    Total Debt

    n/a
    		 1.92M

    Net Cash

    n/a
    		 58.12M

    Retained Earnings

    n/a
    		 -359.31M

    Total Assets

    n/a
    		 45.74M

    Working Capital

    n/a
    		 24.06M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -82.35M and capital expenditures -44K, giving a free cash flow of -82.39M.

    Operating Cash Flow

    n/a
    		 -82.35M

    Capital Expenditures

    n/a
    		 -44K

    Free Cash Flow

    n/a
    		 -82.39M

    FCF Per Share

    n/a
    		 -1.25
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    IOBT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IOBT is $10, which is 619.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 619.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -15.62

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist